| Sector |
Miscellaneous
|
Compare with Sector peers |
| Industry |
Miscellaneous
|
Compare with Industry peers |
| Website | http://www.epbiocomposites.com | |
| Market Cap | 30.80 Cr. | |
| Enterprise Value(EV) | 34.75 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 4.81 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 38.05 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 18.95 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 49.65 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 3.69 | Calculated using Price: 183.15 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.17 Cr. | 1,681,500 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| No Company Profile found. | ||
| 1 Day |
|
|
| 1 Week |
|
+0.19% |
| 1 Month |
|
-2.53% |
| 3 Month |
|
-30.04% |
| 6 Month |
|
|
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 110.53 | 172.53 | 67.88 | |
| Return on Capital Employed (%) | 140.00 | 222.95 | 41.82 | |
| Return on Assets (%) | 5.71 | 38.18 | 15.27 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 0 | 0 | 2 | |
| Non Curr. Liab. | 2 | |||
| Curr. Liab. | 1 | 1 | 5 | |
| Minority Int. | ||||
| Equity & Liab. | 1 | 1 | 9 | |
| Non Curr. Assets | 0 | 1 | ||
| Curr. Assets | 1 | 1 | 9 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 1 | 1 | 9 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 1 | 3 | 8 | |
| Other Income | 0 | |||
| Total Income | 1 | 3 | 8 | |
| Total Expenditure | -1 | -2 | -7 | |
| PBIDT | 0 | 0 | 1 | |
| Interest | 0 | |||
| Depreciation | 0 | |||
| Taxation | 0 | 0 | 0 | |
| Exceptional Items | ||||
| PAT | 0 | 0 | 1 | |
| Adjusted EPS | 1 | 10 | 7 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -4 | |
| Cash Fr. Inv. | 0 | |||
| Cash Fr. Finan. | 5 | |||
| Net Change | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 | 0 |
|
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 To Bombay Stock Exchange LimitedPhiroze Jeejeebhoy TowersDalal Street Mumbai - 400 001Central Depository Services (India) LimitedMarathon Futurex Lower Parel Mumbai - 400 013National Securities Depository LimitedKamala Mills Compound Lower Parel Mumbai - 400 013SUB: Covering letter for Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on December 31 2022Dear Sir/Madam In relation to above mentioned caption please find enclosed herewith Certificate from Bigshare Services Private Limited in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on December 31 2022.Please take the above information on record.Thanking you Yours faithfully For EP Biocomposites LimitedCS Akshada NeuguiCompany Secretary & Compliance Officer |
|
Sat, 12 Nov 2022
Outcome Of Board Meeting Dated 12.11.2022 For Adoption Of Unaudited Financial Results For Half Year Ended September 30 2022 Dear Sir/Madam Sub: Outcome of Board Meeting & Submission of Unaudited Financial Results for Half-Year ended September 30 2022In continuation of our intimation dated November 05 2022 pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the Unaudited Financial Results for the Half Year ended September 30 2022 duly approved by the Board of Directors of the Company in their meeting held today i.e. November 12 2022 together with Statement of Assets and Liabilities and Limited Review Report thereon are enclosed herewith. The Board Meeting commenced at 04.10 P.M. and concluded at 04.30 P.M.The aforesaid results are also being disseminated on Companys website at www.epbiocomposites.com You are hereby requested to kindly take the above information on record.Thanking You.Yours faithfully FOR EP BIOCOMPOSITES LIMITEDAkshada NeuguiCompany Secretary and Compliance Officer |
|
Sat, 05 Nov 2022
Board Meeting Intimation for Adoption Of Unaudited Financial Results For Quarter Ended September 30 2022 EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve ITEM NO. 1: To elect the Chairperson of the Meeting.ITEM NO. 2: To ascertain quorum for the meeting and grant leave of absence.ITEM NO. 3: To note and take on record the minutes of the 19th Board Meeting held on Monday 03rd day of October 2022.ITEM NO. 4: To note and take on record Resolution(s) passed through circulation.ITEM NO. 5: To consider and approve Un-audited Financial Results of the Company with limited review report for half-year ended September 30 2022.ITEM NO. 6: To transact any other business with the permission of the Chair. |
| Wed, 25 Jan 2023 |
High Delivery Percentage
|
Close Crossing Last Month Close from Above
|
Closing Below Previous Low
|
Making Higher Highs for 3 days
|
Close Within 52 Week Low Zone
|
Equities
M.F.
Sectors